253 related articles for article (PubMed ID: 16221232)
1. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients.
Tong NK; Beran J; Kee SA; Miguel JL; Sánchez C; Bayas JM; Vilella A; de Juanes JR; Arrazola P; Calbo-Torrecillas F; de Novales EL; Hamtiaux V; Lievens M; Stoffel M
Kidney Int; 2005 Nov; 68(5):2298-303. PubMed ID: 16221232
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients.
Nevens F; Zuckerman JN; Burroughs AK; Jung MC; Bayas JM; Kallinowski B; Rivas EF; Duvoux C; Neuhaus P; Saliba F; Buti M; Zarski JP; Pons F; Vanlemmens C; Hamtiaux V; Stoffel M
Liver Transpl; 2006 Oct; 12(10):1489-95. PubMed ID: 16964595
[TBL] [Abstract][Full Text] [Related]
3. Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine.
Surquin M; Tielemans CL; Kulcsár I; Ryba M; Vörös P; Mat O; Treille S; Dhaene M; Stolear JC; Kuriyakose SO; Leyssen MX; Houard SA
Kidney Int; 2010 Feb; 77(3):247-55. PubMed ID: 19940840
[TBL] [Abstract][Full Text] [Related]
4. Anti-HBs antibody persistence following primary vaccination with an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency.
Surquin M; Tielemans C; Nortier J; Jadoul M; Peeters P; Ryba M; Roznovsky L; Domán J; Barthelemy X; Crasta PD; Messier M; Houard S
Hum Vaccin; 2011 Sep; 7(9):913-8. PubMed ID: 21892006
[TBL] [Abstract][Full Text] [Related]
5. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients.
Kong NC; Beran J; Kee SA; Miguel JL; Sánchez C; Bayas JM; Vilella A; Calbo-Torrecillas F; López de Novales E; Srinivasa K; Stoffel M; Hoet B
Kidney Int; 2008 Apr; 73(7):856-62. PubMed ID: 18160963
[TBL] [Abstract][Full Text] [Related]
6. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials.
Tielemans CL; Vlasak J; Kosa D; Billiouw JM; Verpooten GA; Mezei I; Ryba M; Peeters PC; Mat O; Jadoul MY; Polakovic V; Dhaene M; Treille S; Kuriyakose SO; Leyssen M; Houard SA; Surquin M
Vaccine; 2011 Feb; 29(6):1159-66. PubMed ID: 21167859
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients.
Beran J
Expert Opin Biol Ther; 2008 Feb; 8(2):235-47. PubMed ID: 18194079
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04.
Boland G; Beran J; Lievens M; Sasadeusz J; Dentico P; Nothdurft H; Zuckerman JN; Genton B; Steffen R; Loutan L; Van Hattum J; Stoffel M
Vaccine; 2004 Dec; 23(3):316-20. PubMed ID: 15530674
[TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study.
Fabrizi F; Tarantino A; Castelnovo C; Martin P; Messa P
Kidney Blood Press Res; 2015; 40(6):584-92. PubMed ID: 26566033
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
[TBL] [Abstract][Full Text] [Related]
13. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
[TBL] [Abstract][Full Text] [Related]
14. Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: randomized study in healthy girls.
Schmeink CE; Bekkers RL; Josefsson A; Richardus JH; Berndtsson Blom K; David MP; Dobbelaere K; Descamps D
Vaccine; 2011 Nov; 29(49):9276-83. PubMed ID: 21856349
[TBL] [Abstract][Full Text] [Related]
15. A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults.
Levie K; Gjorup I; Skinhøj P; Stoffel M
Scand J Infect Dis; 2002; 34(8):610-4. PubMed ID: 12238579
[TBL] [Abstract][Full Text] [Related]
16. A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine.
Dupont J; Altclas J; Lepetic A; Lombardo M; Vázquez V; Salgueira C; Seigelchifer M; Arndtz N; Antunez E; von Eschen K; Janowicz Z
Vaccine; 2006 Nov; 24(49-50):7167-74. PubMed ID: 16884836
[TBL] [Abstract][Full Text] [Related]
17. HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population.
Fabrizi F; Cerutti R; Nardelli L; Tripodi F; Messa P
Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):49-56. PubMed ID: 31327620
[TBL] [Abstract][Full Text] [Related]
18. New hepatitis B vaccine formulated with an improved adjuvant system.
Kundi M
Expert Rev Vaccines; 2007 Apr; 6(2):133-40. PubMed ID: 17408363
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study.
Girndt M; Plüer M; Dellanna F; Michelsen AK; Beige J; Toussaint K; Wehweck HJ; Koch M; Hafezi Rachti S; Faust J; Bosselmann HP; Witzke O; Janssen RS;
Hum Vaccin Immunother; 2022 Nov; 18(6):2136912. PubMed ID: 36269938
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease.
Janssen RS; Mangoo-Karim R; Pergola PE; Girndt M; Namini H; Rahman S; Bennett SR; Heyward WL; Martin JT
Vaccine; 2013 Nov; 31(46):5306-13. PubMed ID: 23727422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
